NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/03/2020
Back to search
Official data from USPTO
ONCOLINJECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
08/03/2020
Trademark type
Word
Nice classes
5
Filing date
11/19/2008
Registration date
05/25/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2020
Last transaction
08/03/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/27/2009
First use in commerce
12/08/2009
Drawing code
4
Owner type
16
Owner location
San Diego, CA
Examiner
NADELMAN, ANDREA
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
THERINJECT LLC
Representatives
THERINJECT LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; Biochemical preparations for medical or veterinary purposes; Cells for medical or clinical use
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/03/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/02/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/25/2019
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/24/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/24/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/24/2016
ES8R
TEAS SECTION 8 RECEIVED
03/06/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/17/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/16/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/15/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2010
ALIE
ASSIGNED TO LIE
04/12/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2010
GNRT
NON-FINAL ACTION E-MAILED
02/02/2010
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/02/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/25/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/25/2010
IUAF
USE AMENDMENT FILED
12/11/2009
EISU
TEAS STATEMENT OF USE RECEIVED
12/11/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/23/2009
PUBO
PUBLISHED FOR OPPOSITION
03/31/2009
NPUB
NOTICE OF PUBLICATION
03/11/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2009
ALIE
ASSIGNED TO LIE
02/25/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2009
DOCK
ASSIGNED TO EXAMINER
02/19/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
11/25/2008
NWAP
NEW APPLICATION ENTERED
11/24/2008
Continuous trademark protection
Get notified about every new filing that threatens ONCOLINJECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.